Alzheimer’s disease is a progressive neurodegenerative disorder that gradually impacts memory, cognition, and behavior. As the global burden of dementia increases, innovative treatment approaches are gaining attention for their potential to enhance patient care. One such innovation is the Rivastigmine Transdermal Patch, a convenient and effective alternative to traditional oral medication.

What is Rivastigmine?

Rivastigmine is a cholinesterase inhibitor used primarily for the treatment of mild to moderate dementia associated with Alzheimer’s and Parkinson’s diseases. It works by increasing levels of acetylcholine in the brain, a chemical involved in memory and learning.

Why Use the Rivastigmine Transdermal Patch?

Unlike oral medications, which may cause gastrointestinal side effects or require multiple daily doses, the Rivastigmine Transdermal Patch offers a steady release of medication through the skin. This delivery system not only improves medication adherence but also reduces the incidence of nausea and vomiting—common issues with the oral form.

Key Benefits of the Patch:

• Once-daily application ensures consistent drug levels

• Improved patient compliance, especially in elderly or cognitively impaired individuals

• Fewer gastrointestinal side effects

• Non-invasive and easy to use

Understanding Rivastigmine Patch Dosage

Correct dosage plays a crucial role in the effectiveness and safety of treatment. The Rivastigmine patch dosage typically begins at a lower strength and may be increased gradually based on the patient’s response and tolerability.

Common Dosage Guidelines:

• Initial dose: 4.6 mg/24 hours

• Maintenance dose: After a minimum of 4 weeks, if well tolerated, the dose may be increased to 9.5 mg/24 hours

• Maximum dose: Some patients may benefit from a further increase to 13.3 mg/24 hours, after evaluation by a healthcare professional

Always consult with your physician before making any changes in dosage. It’s also important to apply the patch to a clean, dry, hairless area on the back, chest, or upper arm and rotate the application site daily.

HETRIVA – A Trusted Brand in Transdermal Therapy

Hetero Healthcare’s HETRIVA Patch is a reliable formulation of the Rivastigmine Transdermal Patch, offering clinical efficacy and patient comfort. Developed with precision, HETRIVA supports caregivers and healthcare providers in ensuring consistent dementia care with minimal disruption to daily life.

Final Thoughts

Dementia care requires a combination of medical management, compassion, and simplicity. The Rivastigmine Transdermal Patch bridges that gap by delivering effective medication in a patient-friendly format. As a part of a holistic Alzheimer’s treatment plan, it ensures better adherence, fewer side effects, and improved outcomes for patients and caregivers alike.